Hospital-acquired infections (HAIs), also known as nosocomial infections, are infections that patients acquire during hospital stays, typically after 48 hours of admission. Common HAIs include bloodstream infections, urinary tract infections, surgical site infections, and pneumonia, often caused by multidrug-resistant organisms. These infections not only increase patient morbidity and mortality but also extend hospital stays and add a significant financial burden to healthcare systems. Effective infection control protocols, antimicrobial stewardship, and improved sanitation practices are key to reducing the prevalence of HAIs.
Market Analysis: In 2025, the global market addressing HAIs—including diagnostics, infection prevention technologies, and treatments—is estimated at USD 31.4 billion. With rising antimicrobial resistance, stricter hospital regulations, and increasing adoption of sterilization and monitoring technologies, the market is projected to grow to USD 49.7 billion by 2030, at a CAGR of 9.6%. North America and Europe dominate due to advanced hospital infrastructure, while Asia-Pacific is witnessing the fastest growth owing to rising healthcare investments and expanding patient populations.
